What Are the Indications for Lorlatinib (Lorviqua)?-Seagull Pharmacy

new

What Are the Indications for Lorlatinib (Lorviqua)?

513

Article source: Seagull Pharmacy

Jan 07, 2026

Lorlatinib (Lorviqua) is an oral tyrosine kinase inhibitor primarily indicated for the treatment of specific types of non-small cell lung cancer (NSCLC). It provides a crucial therapeutic option for patients with advanced lung cancer who harbor certain gene mutations.

What Are the Indications for Lorlatinib (Lorviqua)?

Primary Indications

Lorlatinib has a well-defined targeted therapy indication, which is mainly for adult patients with metastatic non-small cell lung cancer (NSCLC).

Its administration is conditional on the confirmation that the patient’s tumor is anaplastic lymphoma kinase (ALK)-positive, using a testing method approved by the U.S. Food and Drug Administration (FDA).

Dosage Forms and Appearance of Lorlatinib (Lorviqua)

25 mg Tablet

Tablets of this dosage form are round, with a diameter of 8 mm, and tan in color.

They are immediate-release tablets, engraved with "Pfizer" on one side and marked with "25" and "LLN" on the other side.

100 mg Tablet

Tablets of this dosage form are oval-shaped, measuring 8.5 mm × 17 mm, and lavender in color.

Also formulated as immediate-release tablets, they are engraved with "Pfizer" on one side and marked with "LLN100" on the other side.

Precautions

Tablets of both dosage forms are designed to be swallowed whole, and should not be chewed, crushed, or split.

Tablets that are broken, cracked, or incomplete should not be taken.

The medication is packaged in child-resistant bottles. Common packaging configurations include 30 or 120 tablets per bottle for the 25 mg strength, and 30 tablets per bottle for the 100 mg strength.

Storage Conditions for Lorlatinib (Lorviqua)

Storage Temperature

Storage at room temperature between 20°C and 25°C (68°F and 77°F) is recommended.

Short-term storage at temperatures ranging from 15°C to 30°C (59°F to 86°F) is permitted during transportation or temporary carrying.

Storage Environment

The medication should be kept in its original packaging bottle, placed in a dry place, and protected from direct sunlight and moisture.

Ensure the bottle cap is tightly closed to take advantage of its child-resistant feature.

Safe Storage

All medications must be stored out of the reach and sight of children and pets to prevent accidental ingestion.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.

Recommended Articles

Channels for Purchasing Lorlatinib (Lorviqua)

Lorlatinib (Lorviqua) is a third-generation ALK inhibitor, offering an important treatment option for lung cancer patients. How to obtain the medication safely and in compliance with regulations, whil...

Dosage, Administration and Recommended Dose of Ivosidenib (Tibsovo)

Ivosidenib (Tibsovo) is the first targeted therapy indicated for acute myeloid leukemia (AML) with IDH1 mutations, and its standardized administration is crucial for treatment efficacy.Dosage, Adminis...

Channels for Purchasing Tibsovo® (Ivosidenib)

Tibsovo® (Ivosidenib) is an oral targeted therapy indicated for IDH1 mutations. It has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of specific types of acute myeloid...

Adverse Reactions of Capmatinib (Tabrecta)

Capmatinib (Tabrecta) is a highly selective MET kinase inhibitor that has become an important targeted therapy for the treatment of metastatic non-small cell lung cancer (NSCLC) harboring MET exon 14 ...

What Are the Indications of Ivosidenib (Tibsovo)?

Ivosidenib (Tibsovo) is an important isocitrate dehydrogenase-1 (IDH1) inhibitor, providing an innovative treatment option for patients with various malignant tumors harboring IDH1 mutations.What Are ...

Dosage and Administration, Recommended Dose of Lorlatinib (Lorviqua)

Lorlatinib (Lorviqua), a third-generation ALK inhibitor, demonstrates remarkable efficacy in the treatment of ALK-positive non-small cell lung cancer (NSCLC).Dosage and Administration, Recommended Dos...

What are the Precautions for Lorlatinib (Lorviqua) Administration?

Lorlatinib (Lorviqua) is a third-generation anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitor that has demonstrated breakthrough efficacy in the treatment of ALK-positive non-small cell lung ...

Adverse Reactions of Lorlatinib (Lorviqua)

Lorlatinib (Lorviqua) is a third-generation ALK inhibitor that demonstrates significant efficacy in the treatment of ALK-positive non-small cell lung cancer. However, its administration may be accompa...

Contraindications and adverse reactions of itraconazole

Although eltrombopag has no absolute contraindications, it has clear warnings and potential serious adverse reactions. Understanding these risks is a prerequisite for safe medication use.I. Contraindi...

Special population medication of eltrombopag

The use of eltrombopag in special populations requires individualized adjustment. This article reviews key medication points around factors such as hepatic and renal function, age, and ethnicity.I. Do...

Precautions for healthy diet of patients with eltrombopag

When taking eltrombopag, diet directly affects drug absorption and efficacy. Mastering the correct dietary principles is an important part of ensuring safe and effective treatment.I. Timing of Medicat...

Contraindications and adverse reactions of Epclusa

Epclusa is generally well tolerated, but contraindications and adverse reactions require special attention when combined with ribavirin. The following explains from three aspects.I. Contraindications1...

Special population use of Epclusa

Epclusa requires no dosage adjustment in most special populations, but some populations require careful evaluation. The following explains three situations separately.I. Populations with Abnormal Live...

Precautions for healthy diet of patients with Epclusa

During treatment with Epclusa, there are no special dietary restrictions, but a reasonable diet can help reduce discomfort and ensure efficacy. The following explains from three aspects.I. Administrat...

Contraindications and Adverse Reactions of Capmatinib

Capmatinib is used for metastatic non-small cell lung cancer with a mutation that leads to MET exon 14 skipping. It has no absolute contraindications, but several adverse reactions require close monit...

Dietary precautions for patients with Capmatinib

Capmatinib may be taken with or without food, but dietary components, dosing habits, and concomitant medications can directly affect efficacy and safety. The following explains administration, dietary...

Core Drugs